Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic LeukemiaSheila Soh(Duke-NUS Medical School), S. Tiong Ong(Singapore General Hospital)PLoS ONEAugust 4, 201410.1371/journal.pone.0103435Cited by 11SaveCiteExport RISWatch citationsRelated PapersIdentification of cis-Acting Elements and Splicing Factors Involved in the Regulation of BIM Pre-mRNA Splicing|PLoS ONE|2014|34The <i>BIM</i> deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia|Oncotarget|2015|19